Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT00447434
Eligibility Criteria:
Inclusion Criteria:
* In order to be enrolled in the study, potential study subjects must meet the following inclusion criteria:
1. Men and non-pregnant women who are at least 20 and younger than 70 years of age.
2. Subjects who are, in the opinion of the Investigator, able to comply with the requirements of the study.
3. Subjects who have been adequately informed of the nature and risks of the study and who have given written informed consent prior to receiving investigational product.
Group-specific inclusions criteria:
Group A:
1. Subjects have no risk factors of cardiovascular diseases (see Group C) or chronic renal diseases in the history.
2. Male subjects have Creatinine≦1.4 mg/dl; Female≦1.3 mg/dl.
Group B:
1\. Patients have been receiving dialysis at the same institute for at least 3 months.
Group C:
1. Patients have coronary artery disease (CAD); OR
2. Patients have peripheral arterial occlusive disease (PAOD); OR
3. Patients have history of stroke; OR
4. Patients have history of transient ischemic attack (TIA); OR
5. Patients have history of pulmonary embolism (PE); OR
6. Patients have history of deep vein thrombosis (DVP); OR
7. Patients have more than 2 major risk factors of cardiovascular disease (CVD) listed by National Health Insurance guidelines such as hypertension, smoking, diabetes mellitus (DM), atrial fibrillation (AF), lipid disorder, overweight, physical inactivity, etc.
Exclusion Criteria:
* In order to be enrolled in the study, potential study patients must not have any of the following exclusion criteria:
1. Known allergies to the component of study product.
2. Current use of warfarin.
3. Patients have active disease status.
4. Patients have acute disease, and in the opinion of investigators, are not suitable to participate in this study.
Group-specific exclusion criteria:
Group A:
1. Patients have coronary artery disease (CAD).
2. Patients have peripheral arterial occlusive disease (PAOD).
3. Patients have history of stroke.
4. Patients have history of transient ischemic attack (TIA).
5. Patients have history of pulmonary embolism (PE).
6. Patients have history of deep vein thrombosis (DVP).
7. Patients have more than 2 major risk factors of cardiovascular disease (CVD) listed by National Health Insurance guidelines such as hypertension, smoking, diabetes mellitus (DM), atrial fibrillation (AF), lipid disorder, overweight, physical inactivity, etc.
8. Patients have history of chronic renal diseases.
9. Male subjects have Creatinine\>1.4 mg/dl; Female\>1.3 mg/dl.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT00447434
Study Brief:
Protocol Section:
NCT00447434